vs
FIRST BANCORP（FBNC）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
FIRST BANCORP的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.2倍（$89.6M vs $75.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs -7.3%），FIRST BANCORP自由现金流更多（$48.2M vs $14.4M）
第一银行控股（First Bancorp）是总部位于美国北卡罗来纳州南派恩斯的银行控股集团，旗下第一银行业务覆盖北卡罗来纳州与南卡罗来纳州两大区域，为当地客户提供各类银行金融服务。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
FBNC vs PBYI — 直观对比
营收规模更大
FBNC
是对方的1.2倍
$75.5M
营收增速更快
PBYI
高出35.0%
-7.3%
自由现金流更多
FBNC
多$33.8M
$14.4M
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $89.6M | $75.5M |
| 净利润 | $20.4M | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | 29.0% | 22.7% |
| 净利率 | 22.7% | — |
| 营收同比 | -7.3% | 27.7% |
| 净利润同比 | 9.0% | — |
| 每股收益（稀释后） | $0.49 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FBNCPBYI
| Q4 25 | — | $75.5M | ||
| Q3 25 | $89.6M | $54.5M | ||
| Q2 25 | $111.0M | $52.4M | ||
| Q1 25 | $105.8M | $46.0M | ||
| Q4 24 | — | $59.1M | ||
| Q3 24 | $96.6M | $80.5M | ||
| Q2 24 | $95.7M | $47.1M | ||
| Q1 24 | $92.2M | $43.8M |
净利润FBNCPBYI
| Q4 25 | — | — | ||
| Q3 25 | $20.4M | $8.8M | ||
| Q2 25 | $38.6M | $5.9M | ||
| Q1 25 | $36.4M | $3.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | $18.7M | $20.3M | ||
| Q2 24 | $28.7M | $-4.5M | ||
| Q1 24 | $25.3M | $-4.8M |
毛利率FBNCPBYI
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
营业利润率FBNCPBYI
| Q4 25 | — | 22.7% | ||
| Q3 25 | 29.0% | 17.6% | ||
| Q2 25 | 44.9% | 12.7% | ||
| Q1 25 | 44.2% | 8.7% | ||
| Q4 24 | — | 22.6% | ||
| Q3 24 | 23.4% | 27.4% | ||
| Q2 24 | 38.5% | -4.6% | ||
| Q1 24 | 34.5% | -5.3% |
净利率FBNCPBYI
| Q4 25 | — | — | ||
| Q3 25 | 22.7% | 16.2% | ||
| Q2 25 | 34.7% | 11.2% | ||
| Q1 25 | 34.4% | 6.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | 19.3% | 25.2% | ||
| Q2 24 | 30.0% | -9.6% | ||
| Q1 24 | 27.4% | -11.0% |
每股收益（稀释后）FBNCPBYI
| Q4 25 | — | $0.26 | ||
| Q3 25 | $0.49 | $0.17 | ||
| Q2 25 | $0.93 | $0.12 | ||
| Q1 25 | $0.88 | $0.06 | ||
| Q4 24 | — | $0.40 | ||
| Q3 24 | $0.45 | $0.41 | ||
| Q2 24 | $0.70 | $-0.09 | ||
| Q1 24 | $0.61 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $97.5M |
| 总债务越低越好 | $92.4M | $22.7M |
| 股东权益账面价值 | $1.6B | $130.3M |
| 总资产 | $12.8B | $216.3M |
| 负债/权益比越低杠杆越低 | 0.06× | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资FBNCPBYI
| Q4 25 | — | $97.5M | ||
| Q3 25 | — | $94.4M | ||
| Q2 25 | — | $96.0M | ||
| Q1 25 | — | $93.2M | ||
| Q4 24 | — | $101.0M | ||
| Q3 24 | — | $96.7M | ||
| Q2 24 | — | $96.8M | ||
| Q1 24 | — | $107.2M |
总债务FBNCPBYI
| Q4 25 | — | $22.7M | ||
| Q3 25 | $92.4M | $34.0M | ||
| Q2 25 | $92.2M | $45.3M | ||
| Q1 25 | $92.1M | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | $91.7M | $79.3M | ||
| Q2 24 | $91.5M | $90.7M | ||
| Q1 24 | $332.3M | $102.0M |
股东权益FBNCPBYI
| Q4 25 | — | $130.3M | ||
| Q3 25 | $1.6B | $115.3M | ||
| Q2 25 | $1.6B | $104.7M | ||
| Q1 25 | $1.5B | $97.1M | ||
| Q4 24 | — | $92.1M | ||
| Q3 24 | $1.5B | $71.1M | ||
| Q2 24 | $1.4B | $48.5M | ||
| Q1 24 | $1.4B | $51.0M |
总资产FBNCPBYI
| Q4 25 | — | $216.3M | ||
| Q3 25 | $12.8B | $202.9M | ||
| Q2 25 | $12.6B | $194.9M | ||
| Q1 25 | $12.4B | $196.2M | ||
| Q4 24 | — | $213.3M | ||
| Q3 24 | $12.2B | $220.7M | ||
| Q2 24 | $12.1B | $205.0M | ||
| Q1 24 | $12.1B | $214.1M |
负债/权益比FBNCPBYI
| Q4 25 | — | 0.17× | ||
| Q3 25 | 0.06× | 0.30× | ||
| Q2 25 | 0.06× | 0.43× | ||
| Q1 25 | 0.06× | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | 0.06× | 1.12× | ||
| Q2 24 | 0.07× | 1.87× | ||
| Q1 24 | 0.24× | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $49.7M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $48.2M | $14.4M |
| 自由现金流率自由现金流/营收 | 53.8% | 19.1% |
| 资本支出强度资本支出/营收 | 1.6% | 0.0% |
| 现金转化率经营现金流/净利润 | 2.44× | — |
| 过去12个月自由现金流最近4个季度 | $182.9M | $41.7M |
8季度趋势，按日历期对齐
经营现金流FBNCPBYI
| Q4 25 | — | $14.4M | ||
| Q3 25 | $49.7M | $9.7M | ||
| Q2 25 | $45.7M | $14.1M | ||
| Q1 25 | $52.6M | $3.6M | ||
| Q4 24 | — | $15.6M | ||
| Q3 24 | $38.4M | $11.0M | ||
| Q2 24 | $87.7M | $1.0M | ||
| Q1 24 | $-20.1M | $11.2M |
自由现金流FBNCPBYI
| Q4 25 | — | $14.4M | ||
| Q3 25 | $48.2M | $9.7M | ||
| Q2 25 | $44.3M | $14.1M | ||
| Q1 25 | $52.4M | $3.6M | ||
| Q4 24 | — | $15.6M | ||
| Q3 24 | $38.0M | $11.0M | ||
| Q2 24 | $87.6M | $1.0M | ||
| Q1 24 | $-21.7M | — |
自由现金流率FBNCPBYI
| Q4 25 | — | 19.1% | ||
| Q3 25 | 53.8% | 17.7% | ||
| Q2 25 | 39.9% | 26.8% | ||
| Q1 25 | 49.5% | 7.7% | ||
| Q4 24 | — | 26.4% | ||
| Q3 24 | 39.3% | 13.7% | ||
| Q2 24 | 91.6% | 2.1% | ||
| Q1 24 | -23.6% | — |
资本支出强度FBNCPBYI
| Q4 25 | — | 0.0% | ||
| Q3 25 | 1.6% | 0.0% | ||
| Q2 25 | 1.2% | 0.0% | ||
| Q1 25 | 0.2% | 0.1% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | 0.5% | 0.0% | ||
| Q2 24 | 0.1% | 0.0% | ||
| Q1 24 | 1.8% | 0.0% |
现金转化率FBNCPBYI
| Q4 25 | — | — | ||
| Q3 25 | 2.44× | 1.10× | ||
| Q2 25 | 1.19× | 2.41× | ||
| Q1 25 | 1.44× | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.06× | 0.54× | ||
| Q2 24 | 3.06× | — | ||
| Q1 24 | -0.80× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
